[Lymphocytic colitis and ticlopidine].
Brigot
C
C
Courillon-Mallet
A
A
Roucayrol
A M
AM
Cattan
D
D
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000368:Aged; D002216:Captopril / Q000627:therapeutic use; D003092:Colitis / Q000139:chemically induced* / Q000150:complications / Q000473:pathology; D003967:Diarrhea / Q000139:chemically induced* / Q000150:complications; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D002546:Ischemic Attack, Transient / Q000150:complications / Q000188:drug therapy; D008214:Lymphocytes; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013988:Ticlopidine / Q000009:adverse effects*
D000317:Adrenergic alpha-Antagonists; D010975:Platelet Aggregation Inhibitors; D002216:Captopril; D013988:Ticlopidine
Colite lymphocytaire et ticlopidine.